焦虑抑郁共病障碍的研究进展

doi:10.3969/j.issn.2095-1396.2017.06.005

摘要/Abstract

摘要：

传统观点将焦虑障碍和抑郁障碍视为两个独立的疾病单元，然而，在临床实践和流行病学调查中，焦虑抑郁共病的发病率高，且预后差。该文介绍了共病障碍的基本概念，共病特点，治疗措施以及相关的动物模型，着重讨论新的动物模型的建立和新型抗焦虑和抗抑郁双重治疗药物的开发对焦虑和抑郁共病障碍诊断、治疗和预防的积极意义。

关键词: 焦虑, 抑郁, 共患病, 动物模型

Abstract:

It is traditionally thought that anxiety disorder and depressive disorder are categorically defined as two individual psychiatric disorders. As clinical practice and epidemiological studies show，however，the comorbidity of depression and anxiety is prevalent and of poorer outcomes than either disorder alone. In this review，the concepts，clinical features，therapeutic managements，and animal models related to the comorbidity of depression and anxiety are well addressed. In addition，establishing the novel animal models and developing the new agents of both anti-depression and-anxiety are discussed to improve its diagnosis，treatment，and medical prevention.

Key words: anxiety, depression, comorbidity, animal model

中图分类号:

R964

引用本文

梁慧，程涛，梁建辉. 焦虑抑郁共病障碍的研究进展[J]. 神经药理学报, DOI: 10.3969/j.issn.2095-1396.2017.06.005.

LIANG Hui，CHENG Tao，LIANG Jian-hui. Progress in the Comorbidity of Depression and Anxiety[J]. Acta Neuropharmacologica, DOI: 10.3969/j.issn.2095-1396.2017.06.005.

使用本文

0
/ 推荐

导出引用管理器 EndNote|Ris|BibTeX

链接本文: http://actanp.hebeinu.edu.cn/CN/10.3969/j.issn.2095-1396.2017.06.005

http://actanp.hebeinu.edu.cn/CN/Y2017/V7/I6/30

参考文献

[1] Tabatha H Melton, Paul E Croarkin, Jeffrey R Strawn, et al. Comorbid anxiety and depressive symptoms in children and adolescents: a systematic review and analysis [J]. J Psychiatr Pract, 2016, 22(2):84-98.

[2] Katharina Kircanski, Joelle LeMoult, Sarah Ordaz, et al. Investigating the nature of cooccurring depression and anxiety: Comparing diagnostic and dimensional research approaches [J]. J Affect Disord, 2017, 16:123-135.

[3] Amanda L Rebar, Rob Stanton, Simon Rosenbaum. Comorbidity of depression and anxiety in exercise research [J]. Lancet Psychiatry, 2017, 4(7): 519.

[4] Alvan R Feinstein. The pre-therapeutic classification of co-morbidity in chronic disease [J]. J Chronic Dis, 1970, 23(7): 455-468.

[5] Jules Angst. Depression and anxiety: implications for nosology, course, and treatment[J]. J Clin Psychiatry, 1997, 58(Suppl 8): 3-5.

[6] Van Praag H M. Comorbidity (psycho) analysed [J]. Br J Psychiatry Suppl, 1996, 30: 129-134.

[7] Ron de Graaf, Rob V Bijl, Filip Smit, et al. Risk factors for 12?month comorbidity of mood, anxiety, and substance use disorders: fndings from the Netherlands Mental Health Survey and Incidence Study [J]. Am J Psychiatry, 2002, 159(4): 620?629.

[8] Robert Johansson, Per Carlbring, Asa Heedman, et al. Depression, anxiety and their comorbidity in the Swedish general population: point prevalence and the effect on health-related quality of life [J]. Peer J, 2013, 1:e98.

[9] Michael R Phillips, Zhang Jing-xuan, Shi Qi-chang, et al. Prevalence, treatment, and associated disability of mental disorders in four provinces in China during 2001?05: An epidemiological survey [J]. Lancet, 2009, 373(9680): 2041?2053.

[10] Arjan W Braam, John R M Copeland, Philippe A E G Delespaul, et al. Depression, subthreshold depression and comorbid anxiety symptoms in older Europeans: results from the EURODEP concerted action [J]. J Affect Disord, 2014, 155: 266-272.

[11] Colleen M Cummings, Nicole E Caporino, Philip C Kendall. Comorbidity of anxiety and depression in children and adolescents: 20 years after [J]. Psychol Bull, 2014, 140(3): 816-845.

[12] Ahmet Koyuncu, Erhan Ertekin, Banu Aslantas Ertekin, et al. Relationship between atypical depression and social anxiety disorder [J]. Psychiatry Res, 2015, 225(1-2): 79-84.

[13] Idan M Aderka, Courtney Beard, Josephine Lee, et al. The relationship between depression and generalized anxiety during intensive psychological and pharmacological treatment [J]. J Affect Disord, 2015, 184: 261-268.

[14] Jesper T Andreasen, Ciaran M Fitzpatrick, Maria Larsen, et al. Differential role of AMPA receptors in mouse tests of antidepressant and anxiolytic action [J]. Brain Res, 2015, 1601: 117-126.

[15] Aravind Mittur. Trazodone: properties and utility in multiple disorders [J]. Expert Rev Clin Pharmacol, 2011, 4(2): 181-196.

[16] Rickels K, Downing R, Schweizer E, et al. Antidepressants for the treatment of generalized anxiety disorder. A placebo-controlled comparison of imipramine, trazodone, and diazepam [J]. Arch Gen Psychiatry, 1993, 50(11): 884-895.

[17] Fawcett J, Barkin R L. A meta-analysis of eight randomized, double-blind, controlled clinical trials of mirtazapine for the treatment of patients with major depression and symptoms of anxiety [J]. J Clin Psychiatry, 1998, 59(3): 123-127.

[18] Sarawut Lapmanee, Jantarima Charoenphandhu, Narattaphol Charoenphandhu. Beneficial effects of fluoxetine, reboxetine, venlafaxine, and voluntary running exercise in stressed male rats with anxiety- and depression-like behaviors [J]. Behav Brain Res, 2013, 250: 316-325.

[19] Kostowski W, Dyr W, Krzascik P, et al. 5-Hydroxytryptamine1A receptor agonists in animal models of depression and anxiety [J]. Pharmacol Toxicol, 1992, 71(1): 24-30.

[20] Sramek J J, Tansman M, Suri A, et al. Efficacy of buspirone in generalized anxiety disorder with coexisting mild depressive symptoms [J]. J Clin Psychiatry, 1996, 57(7): 287-91.

[21] 王宪军, 王振英.丁螺环酮与文拉法新联合治疗抑郁焦虑共病对照研究[J]. 新乡医学院学报, 2004, 21(5): 407-408.

[22] Richard C Shelton, Gary D Tollefson, Mauricio Tohen, et al. A novel augmentation strategy for treating resistant major depression [J]. Am J Psychiatry, 2001, 158(1):131-134.

[23] 王坚. 从胆论治冠心病后焦虑、抑郁症[J]. 中国社区医师: 医学专业, 2010, 12(7): 93-94.

[24] 李克建，陈云，郭娟，等. 疏肝解郁胶囊联合草酸艾司西酞普兰治疗脑卒中患者焦虑抑郁状态的疗效观察[J]. 国际精神病学杂志, 2017, 44(2): 260-262+266.

[25] 宋波, 朱功蓓, 林煜涵, 等.解虑安神汤对焦虑小鼠脑内GABA水平及其受体表达的影响[J]. 中药药理与临床, 2013, 29(6): 118-121.

[26] 郭岳峰刘方洲. 解郁安神汤抗抑郁作用的实验研究[J]. 中医研究, 2010, 23(10): 24-26.

[27] 尹东辉, 张晶, 刘纯莉. 乌灵胶囊的临床应用进展[J]. 中国新药杂志, 2011, 20(16)：1530-1533+1562

[28] Jean-Philippe Boulenger, M Fournier, D Rosales, et al. Mixed anxiety and depression: from theory to practice[J]. J Clin Psychiatry, 1997, 58(Suppl 8): 27-34.

[29] Colleen Stiles-Shields, Mary J Kwasny, Cai Xuan, et al. Comorbid anxiety as a differential treatment predictor for telephone versus face-to-face administered cognitive behavioral therapy for depression[J]. Depress Anxiety, 2014, 31(11): 934-940.

[30] Dilip Kumar Pandey, Sushil Kumar Yadav, Radhakrishana Mahesh, et al. Depression-like and anxiety-like behavioural aftermaths of impact accelerated traumatic brain injury in rats: a model of comorbid depression and anxiety? [J]. Behav Brain Res, 2009, 205(2):436-442.

[31] Liu Yu-ting, Shao Yen-wen, Yen Chen-tung, et al. Acid-induced hyperalgesia and anxio- depressive comorbidity in rats [J]. Physiol Behav, 2014, 131: 105-110.

[32] Kenneth J Sufka, Matthew Feltenstein, Jason E Warnick, et al. Modeling the anxiety-depression continuum hypothesis in domestic fowl chicks [J]. Behav Pharmacol, 2006, 17(8): 681-689.

[33] Ana M Basso, Kelly B Gallagher, Natalie A Bratcher, et al. Antidepressant- like effect of D (2/3) receptor-, but not D(4) receptor-activation in the rat forced swim test [J]. Neuropsy-chopharmacology, 2005, 30(7):1257-1268.

[34] Rodrigo Moraga-Amaro, Hugo Gonzalez, Rodrigo Pacheco, et al. Dopamine receptor D3 deficiency results in chronic depression and anxiety [J]. Behav Brain Res, 2014, 274: 186-193.

[35] Lucien Steru, Raymond Chermat, Bernard Thierry, et al. The tail suspension test: a new method for screening antidepressants in mice [J]. Psychopharmacology (Berl), 1985, 85(3):367-370.

[36] Malika El Yacoubi, Saoussen Bouali, Daniela Popa, et al. Behavioral, neurochemical, and electrophysiological characterization of a genetic mouse model of depression [J]. Proc Natl Acad Sci U S A, 2003, 100(10):6227-6232.

[37] Malika El Yacoubi, Virginie Rappeneau, Eddy Champion, et al. The H/Rouen mouse model displays depression-like and anxiety-like behaviors [J]. Behav Brain Res, 2013, 256:43-50.

Catherine S John, Elizaheth I Sypek, William A Carlezon, et al. Blockade of the GLT-1 transporter in the central nucleus of the amygdala induces both anxiety and depressive-like symptoms [J]. Neuropsychopharmacology, 2015, 40(7):1700-1708.

编辑推荐

Metrics

阅读次数

全文

摘要

摘要
参考文献
相关文章
编辑推荐
Metrics

回顶部